![]() | ![]() |
Alembic Pharma Gets USFDA Final Approval for Nelarabine Injection
Alembic Pharmaceuticals has secured final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Nelarabine Injection, 250 mg/50 mL (5 mg/mL) (Single-Dose Vial).
Sandoz | 05/08/2024 | By Aishwarya | 161
Sandoz Acquires Astellas' Antifungal Agent Mycamine
The company stated "Through this acquisition of the leading global echinocandin, one of three major antifungal classes, Sandoz significantly reinforces its global hospital offering and leading anti-infectives portfolio.
Sandoz | 29/08/2023 | By Manvi | 297
Sandoz Technical Operations launches manufacturing plant in Maharashtra
The new facility will produce oncology-focussed medicines covering both cancer and blood disorders
<br />
Sandoz | 01/07/2022 | By Sudeep Soparkar | 1438
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy